London, United Kingdom · Founded 2020 · Privately Held (backing)
Developer of a pipeline of therapeutics designed to transform large protein degraders into small molecules for targeted protein degradation. Kesmalea Therapeutics is based in London, United Kingdom and was founded in 2020. Its last known valuation is $39 million. It has raised $37.8 million.
Last price · $/share
—
Implied valuation
$39.0M
Total raised
$37.8M
Last round
—
Cap table — not yet on record
Kesmalea Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Kesmalea Therapeutics with a free account
·Watch Kesmalea Therapeutics: the Monday email on marks, rounds and moves
